Kineta has completed enrollment in the monotherapy cohorts of the Phase 1 VISTA-101 clinical trial. The ongoing Phase 1 study is now enrolling patients into cohorts evaluating KVA12123 in combination ...
Kineta, Inc. (OTC Pink: KANT) , a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today that its ...
Around 7:45 p.m. on Oct. 15, Northeast Corridor Train 3663 struck and killed the man after the train left Penn Station New ...
The accident occurred shortly after 6 a.m. just north of the Roebling Station in Mansfield Township, NJ Transit said in a ...